[ 52 ] enrolled patients with severe and critical illness and only found a decreasing trend in mortality in the group of severe TCZ treated patients compared with the controls (14.2% vs. 28.6%).
← all excerpts
Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis.
1
—
—